Abstract: There is provided an information processing apparatus and an information processing method capable of improving security against leakage of a registered fingerprint in fingerprint authentication. Collation is performed on the basis of whether or not a feature amount of a partial region of an entire fingerprint imaged by a fingerprint imaging unit and a method of operation on the fingerprint imaging unit match the feature amount of the partial region of the entire fingerprint and the method of operation registered in advance. Application to a fingerprint authentication device is possible.

Abstract: An object of the present invention is to provide a pharmaceutical tablet having high tensile strength and excellent in immediate disintegrability. The pharmaceutical tablet of the present invention is obtained by a direct compression method, and contains an active ingredient, a polyvinyl alcohol resin, and a plasticizer other than water, wherein a content of the plasticizer is 1 to 8 parts by weight with respect to 100 parts by weight of the polyvinyl alcohol resin.

Abstract: A PC causes a printing apparatus to print a color chart sheet including a color chart and a first image, the first image indicating a color measurement start position and a color measurement start direction of a colorimeter in a forward path in a leading line of the color chart.

Abstract: The present invention pertains to hepatocytes, liver progenitor cells, cholangiocytes, liver sinusoidal endothelial progenitor cells, liver sinusoidal endothelial cells, hepatic stellate progenitor cells, hepatic stellate cells, and liver cellular tissue models, as well as to methods for preparing these cells. The present invention also pertains to a cell fraction comprising liver progenitor cells, liver sinusoidal endothelial progenitor cells, or hepatic stellate progenitor cells. The present invention also pertains to a pharmaceutical composition or kit comprising the above-mentioned cells, a liver cellular tissue model, or a cell fraction.

Abstract: An object of the present invention is to provide a pharmaceutical tablet having high tensile strength and excellent in immediate disintegrability. The pharmaceutical tablet of the present invention is obtained by a direct compression method, and contains an active ingredient, a polyvinyl alcohol resin, and a plasticizer other than water, wherein a content of the plasticizer is 1 to 8 parts by weight with respect to 100 parts by weight of the polyvinyl alcohol resin.

Abstract: A driving support apparatus includes an other vehicle detector, an other vehicle information acquisition unit, a proximity detector, a proximity controller and a setting unit. The other vehicle detector detects an other vehicle travelling on the second lane. The other vehicle information acquisition unit acquires information containing the size of the other vehicle. The proximity detector outputs a proximity signal when it is detected that the other vehicle is located in the detection range of set on the second lane at a predetermined detection distance from the own vehicle. The proximity controller activates a proximity control unit when detecting that a turn signal lever is operated while the proximity signal is being output. The setting unit increases the detection distance according to the size of the other vehicle.

Abstract: A driving support apparatus includes an other vehicle detector, an other vehicle information acquisition unit, a proximity detector, a proximity controller and a setting unit. The other vehicle detector detects an other vehicle travelling on the second lane. The other vehicle information acquisition unit acquires information containing the size of the other vehicle. The proximity detector outputs a proximity signal when it is detected that the other vehicle is located in the detection range of set on the second lane at a predetermined detection distance from the own vehicle. The proximity controller activates a proximity control unit when detecting that a turn signal lever is operated while the proximity signal is being output. The setting unit increases the detection distance according to the size of the other vehicle.

Abstract: The present invention pertains to hepatocytes, liver progenitor cells, cholangiocytes, liver sinusoidal endothelial progenitor cells, liver sinusoidal endothelial cells, hepatic stellate progenitor cells, hepatic stellate cells, and liver cellular tissue models, as well as to methods for preparing these cells. The present invention also pertains to a cell fraction comprising liver progenitor cells, liver sinusoidal endothelial progenitor cells, or hepatic stellate progenitor cells. The present invention also pertains to a pharmaceutical composition or kit comprising the above-mentioned cells, a liver cellular tissue model, or a cell fraction.

Abstract: A driving support apparatus includes an other vehicle detector, an other vehicle information acquisition unit, a proximity detector, a proximity controller and a setting unit. The other vehicle detector detects an other vehicle travelling on the second lane. The other vehicle information acquisition unit acquires information containing the size of the other vehicle. The proximity detector outputs a proximity signal when it is detected that the other vehicle is located in the detection range of set on the second lane at a predetermined detection distance from the own vehicle. The proximity controller activates a proximity control unit when detecting that a turn signal lever is operated while the proximity signal is being output. The setting unit increases the detection distance according to the size of the other vehicle.

Abstract: To prevent a decrease in detection accuracy of an obstacle that occurs when an obstacle detection distance of an infrared beam at the center is set longer than an infrared beam of at least one of the left or the right, an obstacle detection device for a vehicle which detects an obstacle in front includes an effective-range control part 19 which controls the maximum effective distance of obstacle detection. The effective-range control part 19 extends the maximum effective distance of the second emitting-and-receiving parts 11b, 11c disposed on at least one of the left or the right from an initial value L1 to an extended value L2, when the first emitting-and-receiving part 11a at the center detects an obstacle 5.

Abstract: To prevent a decrease in detection accuracy of an obstacle that occurs when an obstacle detection distance of an infrared beam at the center is set longer than an infrared beam of at least one of the left or the right, an obstacle detection device for a vehicle which detects an obstacle in front includes an effective-range control part 19 which controls the maximum effective distance of obstacle detection. The effective-range control part 19 extends the maximum effective distance of the second emitting-and-receiving parts 11b, 11c disposed on at least one of the left or the right from an initial value L1 to an extended value L2, when the first emitting-and-receiving part 11a at the center detects an obstacle 5.